Ocular Therapeutix Inc (NASDAQ:OCUL)
| 3.62 Delayed Data As of Dec 08 |  -0.10 / -2.69%Today’s Change | 2.00 Today|||52-Week Range 7.96 | +28.83% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 1.8M | 1.9M | 1.9M | 2.0M | |
| Cost of Goods Sold | 319.0K | 2.5K | 457.0K | 465.0K | ||
| Depreciation And Amortization | 754.0K | 881.0K | 1.6M | 2.3M | ||
| Operating Expenses | Gross Income | 677.0K | 1.0M | -159.0K | -761.0K | |
| General Expenses | 38.9M | 44.3M | 59.3M | 58.4M | ||
| Research And Development | 26.6M | 27.1M | 30.2M | 36.9M | ||
| Total Operating Expenses | 39.9M | 45.2M | 61.3M | 61.1M | ||
| Non-Operating Expenses | Operating Income | -38.2M | -43.3M | -59.4M | -59.1M | |
| Extraordinary Charge | 0.00 | 0.00 | -2.5M | 0.00 | ||
| Interest Expense On Debt | 1.7M | 1.7M | 1.9M | 1.7M | ||
| Other Expenses | 7.0K | -1.0K | 5.0K | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -39.7M | -44.7M | -63.4M | -60.0M | |
| Net Income | -39.7M | -44.7M | -63.4M | -60.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 23.2M | 24.8M | 28.8M | 38.1M | |
| Shares To Calculate EPS Diluted | 23.2M | 24.8M | 28.8M | 38.1M | ||
| Earnings Per Share | EPS | -$1.71 | -$1.80 | -$2.20 | -$1.57 | |
| EPS Diluted | -$1.71 | -$1.80 | -$2.20 | -$1.57 | ||
